Fermitin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Fermitin-2 (also known as Kindlin-2 or MITD2) is a protein encoded by the FERMT2 gene. It is a member of the kindlin family of proteins that play critical roles in integrin activation, cell-matrix adhesion, and cytoskeletal organization. Fermitin-2 has been identified as a risk factor for Alzheimer's disease through genome-wide association studies.
| Attribute | Value |
|---|---|
| Protein Name | Fermitin-2 / Kindlin-2 |
| Gene Symbol | FERMT2 |
| UniProt ID | Q9BUF5 |
| PDB Structure | 5HQ5, 5Y7Z |
| Molecular Weight | ~76 kDa |
| Subcellular Localization | Cytoplasm, plasma membrane, focal adhesions |
| Protein Family | Kindlin family |
Fermitin-2 contains several key structural features:
The protein forms a ternary complex with integrins and talin, enabling integrin activation.
Fermitin-2 plays essential roles in:
In the nervous system, fermitin-2 may contribute to:
GWAS have identified FERMT2 variants as risk factors for late-onset Alzheimer's disease. Potential mechanisms include:
Fermitin-2 is not yet a primary drug target, but approaches include:
Understanding fermitin-2 (also known as kindlin-2 or METAP1) function has important therapeutic implications:
Cancer therapy: Fermitin-2 is overexpressed in several cancers and is involved in cell migration and metastasis. Targeting fermitin-2 may provide therapeutic benefits in cancer treatment.
Fibrosis: Fermitin-2 plays a role in tissue fibrosis through its effects on cell-matrix interactions. Inhibitors may help treat fibrotic diseases.
Neurodegeneration: While less studied in the nervous system, fermitin-2's role in cytoskeletal dynamics and cell adhesion may be relevant to neuronal connectivity and repair mechanisms.
The study of Fermitin 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This page was created on 2026-03-04